Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px
Organisation › Details

Sonata Therapeutics (US)

Sonata Therapeutics is revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. The company's product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through its pioneering science, Sonata identifies new targets for therapeutics that induce the release of a programmed diversity of signals that drive curative microenvironments. Founded in 2022 by Flagship Pioneering, Sonata is generating a growing pipeline of small molecule drugs and genetic therapeutics, with preclinical programs that address a broad range of oncologic indications, as well as exploratory efforts in fibrosis and autoimmune disorders. Sonata Therapeutics was formed by combining two Flagship companies, Inzen Therapeutics and Cygnal Therapeutics, and builds on each company’s pioneering work characterizing different inputs into the cellular microenvironment and their roles in causing disease, and developing therapeutic strategies based on these insights. *


Period Start 2022-05-18 merged
  Predecessor Inzen Therapeutics (US)
Product Industry BIOTECH
Region Region Cambridge, MA
  Country United States (USA)
  City n. a. Cambridge, MA
    Address record changed: 2024-01-05
Basic data Employees n. a.
    * Document for »About Section«: Sonata Therapeutics. (5/18/22). "Press Release: Flagship Pioneering Unveils Sonata Therapeutics to Harness Cellular Microenvironments for the Treatment of Serious Diseases". Cambridge, MA.
Record changed: 2023-07-10


Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Sonata Therapeutics (US)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px

» top